Company / Cost of Revenue
Lantheus Holdings Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$599.7M
FY2025
5-year range
$237.5M / $599.7M
FY2021-FY2025
Trend
+9.9%
vs FY2024
Sector context
#61 of 113
Health Care
What the data says
At $600M, Lantheus Holdings's cost of revenue ranks #53 of 113 in the Health Care sector. Cost of Revenue has fluctuated over the past 10 years, ranging from $158M in FY2017 to $600M in FY2025.
Based on SEC 10-K filings.
$600M in FY2025 with a 5-year CAGR of +24.5%.
Increased from $587M to $600M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +19.3%
- 5-Year CAGR
- +24.5%
- 10-Year CAGR
- -
Sector benchmark
#53 of 113 in Health CareTop 46% of 113This company $599.7M Sector average $11.3B
▼
-94.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +24.5%, indicating consistent growth.
- In FY2025, cost of revenue increased 9.9% year-over-year.
- Ranks #61 out of 113 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $599.7M | +9.9% |
| FY2024 | $545.6M | -7.0% |
| FY2023 | $586.9M | +66.1% |
| FY2022 | $353.4M | +48.8% |
| FY2021 | $237.5M | +18.4% |
| FY2020 | $200.6M | +16.3% |
| FY2019 | $172.5M | +5.2% |
| FY2018 | $164.1M | +3.9% |
| FY2017 | $157.9M | -10.3% |
| FY2016 | $176.1M | -14.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026